Pfizer Inc. (PFE) Q2 2010 Earnings Results

Pfizer Misses on EPS, Stock Up 5.56%

Pfizer's earnings report shows a significant miss on EPS, which may raise concerns among investors about the company's current performance. However, the stock reacted positively, increasing by 5.56%. This could indicate investor confidence in Pfizer's long-term strategies despite the short-term setback in earnings.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.31	N/A	-40.50%

Management

Management commentary

Tone: Defensive

Management expressed concern over recent performance but remains committed to their strategic initiatives. They did not provide specific guidance for future quarters.

Management acknowledged the challenges faced in the quarter.

They emphasized a focus on long-term strategies despite the current EPS miss.

Pfizer Misses on EPS, Stock Up 5.56%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Misses on EPS, Stock Up 5.56%

Key numbers

Management commentary